SCHEMBL26008260

SCHEMBL26008260

CC(=O)CN1CCN(C(=O)NCCOc2ccc(C[C@H](N)C(=O)O)cc2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ITGB3 P05106 3/20 0.48
▸ ITGA2B P08514 3/20 0.48
▸ FAAH O00519 3/20 0.43
▸ HRH2 P25021 7/20 0.42
▸ HRH1 P35367 7/20 0.42
▸ CACNA1F O60840 1/20 0.42
▸ ADORA3 P0DMS8 1/20 0.42
▸ DRD2 P14416 1/20 0.42
▸ TACR2 P21452 1/20 0.42
▸ DRD1 P21728 1/20 0.42
▸ DRD5 P21918 1/20 0.42
▸ ADRA1D P25100 1/20 0.42
▸ TACR1 P25103 1/20 0.42
▸ HTR2A P28223 1/20 0.42
▸ HTR2C P28335 1/20 0.42
▸ HTR7 P34969 1/20 0.42
▸ ADRA1A P35348 1/20 0.42
▸ ADRA1B P35368 1/20 0.42
▸ OPRM1 P35372 1/20 0.42
▸ DRD3 P35462 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31688659 0.93 ITGB3 (0.49) ITGB3ITGA2BFAAHHRH2HRH1
SCHEMBL26009739 0.93 ITGB3 (0.49) ITGB3ITGA2BFAAHHRH2HRH1
SCHEMBL25360874 0.93 ITGB3 (0.49) ITGB3ITGA2BFAAHHRH2HRH1
Bromide SCHEMBL31074002 0.92 ITGB3 (0.48) ITGB3ITGA2BFAAHHRH2HRH1
SCHEMBL26009187 0.84 KDM4E (0.53) SLC7A5HRH3
SCHEMBL26008256 0.84 KDM4E (0.53) SLC7A5HRH3
SCHEMBL26008236 0.82 MEN1 (0.49) ITGB3ITGA2BALDH1A1USP2
SCHEMBL31688810 0.81 HRH2 (0.46) ITGB3ITGA2BFAAHHRH2HRH1
SCHEMBL31688669 0.81 HRH2 (0.46) ITGB3ITGA2BFAAHHRH2HRH1
SCHEMBL21644787 0.79 ITGB3 (0.63) ITGB3ITGA2BALDH1A1PTPN1SLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES DNPEP, BCAT1, ANPEP ITGB3 4109/4885ITGA2B 3548/4885FAAH 4071/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback